High flux haemodialysis maintains lower serum Beta-2-microglobulin levels than conventional haemodialysis regimes.
A Cruickshank(Lister Hospital), Andrew Davenport(The Royal Free Hospital), James Tattersall, T Pickett(Gloucestershire Royal Hospital), Ken Farrington(University of Hertfordshire), Roger Greenwood(Mount Sinai Beth Israel)
UCL Discovery (University College London)
May 1, 1999
Cited by 0
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Vascular access use in Europe and the United States: Results from the DOPPS
|Kidney International|2002|855
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
|Nephrology Dialysis Transplantation|2013|476